LIM domain only 2 over-expression in prostate stromal cells facilitates prostate cancer progression through paracrine of Interleukin-11

Oncotarget. 2016 May 3;7(18):26247-58. doi: 10.18632/oncotarget.8359.

Abstract

Mechanisms of stromal-epithelial crosstalk are essential for Prostate cancer (PCa) tumorigenesis and progression. Peripheral zone of the prostate gland possesses a stronger inclination for PCa than transition zone. We previously found a variety of genes that differently expressed among different prostate stromal cells, including LIM domain only 2 (LMO2) which highly expressed in peripheral zone derived stromal cells (PZSCs) and PCa associated fibroblasts (CAFs) compared to transition zone derived stromal cells (TZSCs). Studies on its role in tumors have highlighted LMO2 as an oncogene. Herein, we aim to study the potential mechanisms of stromal LMO2 in promoting PCa progression. The in vitro cells co-culture and in vivo cells recombination revealed that LMO2 over-expressed prostate stromal cells could promote the proliferation and invasiveness of either prostate epithelial or cancer cells. Further protein array screening confirmed that stromal LMO2 stimulated the secretion of Interleukin-11 (IL-11), which could promote proliferation and invasiveness of PCa cells via IL-11 receptor α (IL11Rα) - STAT3 signaling. Moreover, stromal LMO2 over-expression could suppress miR-204-5p which was proven to be a negative regulator of IL-11 expression. Taken together, results of our study demonstrate that prostate stromal LMO2 is capable of stimulating IL-11 secretion and by which activates IL11Rα - STAT3 signaling in PCa cells and then facilitates PCa progression. These results may make stromal LMO2 responsible for zonal characteristic of PCa and as a target for PCa microenvironment-targeted therapy.

Keywords: Interleukin-11 (IL-11); LIM domain only 2 (LMO2); prostate cancer; stromal cell; stromal-epithelial crosstalk.

MeSH terms

  • Adaptor Proteins, Signal Transducing / biosynthesis*
  • Animals
  • Disease Progression
  • Heterografts
  • Humans
  • Interleukin-11 / biosynthesis*
  • LIM Domain Proteins / biosynthesis*
  • Male
  • Mice
  • Paracrine Communication / physiology
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology*
  • Proto-Oncogene Proteins / biosynthesis*
  • Stromal Cells / metabolism*
  • Stromal Cells / pathology
  • Up-Regulation

Substances

  • Adaptor Proteins, Signal Transducing
  • IL11 protein, human
  • Interleukin-11
  • LIM Domain Proteins
  • LMO2 protein, human
  • Proto-Oncogene Proteins